Chorion-derived perinatal mesenchymal stem cells improve cardiac function and vascular regeneration: Preferential treatment for ischemic heart disease

Hellenic Journal of Cardiology - Tập 66 - Trang 52-58 - 2022
Yong Soo Park1,2, Bong-Woo Park3,4, Hayoung Choi5,6, Seung Hee Lee1,2, Myungshin Kim5,6, Hun-Jun Park3,4, In-Beom Kim1,2,7
1Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
2Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
3Department of Medical Life Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
4Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea
5Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
6Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea
7Catholic Institute for Applied Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea

Tài liệu tham khảo

Heidenreich Paul, 2013, Forecasting the impact of heart failure in the United States, Circulation: Heart Fail, 6, 606 Nowbar, 2019, Mortality from ischemic heart disease, Circulation: Cardiovascular Quality and Outcomes, 12 Wright, 2018, Million hearts 2022: small steps are needed for cardiovascular disease prevention, JAMA, 320, 1857, 10.1001/jama.2018.13326 Afzal, 2015, Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials, Circ Res, 117, 558, 10.1161/CIRCRESAHA.114.304792 Yau, 2019, Intramyocardial injection of mesenchymal precursor cells and successful temporary weaning from left ventricular assist device support in patients with advanced heart failure: a randomized clinical trial, JAMA, 321, 1176, 10.1001/jama.2019.2341 Curfman, 2019, Stem cell therapy for heart failure: an unfulfilled promise?, JAMA, 321, 1186, 10.1001/jama.2019.2617 Madonna, 2016, Position paper of the European society of cardiology working group cellular biology of the heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure, Eur Heart J, 37, 1789, 10.1093/eurheartj/ehw113 Kwon, 2016, Tissue-specific differentiation potency of mesenchymal stromal cells from perinatal tissues, Sci Rep, 6, 10.1038/srep23544 Li, 2016, How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?, Stem Cell Int, 2016 Ji, 2017, Promising Therapeutic Strategies for Mesenchymal Stem Cell-Based Cardiovascular Regeneration: From Cell Priming to Tissue Engineering, Stem Cell Int, 2017, 3945403 Liu, 2019, Heterogeneity of MSC: Origin, Molecular Identities, and Functionality, Stem Cell Int, 2019, 9281520 Abdelwahid, 2016, Stem cell death and survival in heart regeneration and repair, Apoptosis, 21, 252, 10.1007/s10495-015-1203-4 Ullah, 2015, Human mesenchymal stem cells - current trends and future prospective, Biosci Rep, 35, 10.1042/BSR20150025 Müller, 2018, Stem cell therapy in heart diseases - cell types, mechanisms and improvement strategies, Cell Physiol Biochem, 48, 2607, 10.1159/000492704 Hatzistergos, 2011, What is the oncologic risk of stem cell treatment for heart disease?, Circ Res, 108, 1300, 10.1161/CIRCRESAHA.111.246611 Breitbach, 2007, Potential risks of bone marrow cell transplantation into infarcted hearts, Blood, 110, 1362, 10.1182/blood-2006-12-063412 Gaebel, 2011, Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration, PLoS One, 6, 10.1371/journal.pone.0015652 Passier, 2003, Origin and use of embryonic and adult stem cells in differentiation and tissue repair, Cardiovasc Res, 58, 324, 10.1016/S0008-6363(02)00770-8 Mazhari, 2012, Translational findings from cardiovascular stem cell research, Trends Cardiovasc Med, 22, 1, 10.1016/j.tcm.2012.05.017 Park, 2020, In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair, Sci Adv, 6, eaay6994, 10.1126/sciadv.aay6994 Gronda, 2019, Unresolved issues in left ventricular postischemic remodeling and progression to heart failure, J Cardiovasc Med, 20, 640, 10.2459/JCM.0000000000000834 Chuquiure Valenzuela, 2002, [Heart failure in acute myocardial infarction], Arch Cardiol Mex, 72, S52 Minicucci, 2011, Heart Failure After Myocardial Infarction: Clinical Implications and Treatment, Clin Cardiol, 34, 410, 10.1002/clc.20922 Vizzardi, 2014, Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives, Int J Cardiol Heart Vessel, 3, 6 Wang, 2008, Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction, Cardiovasc Res, 77, 515, 10.1093/cvr/cvm046 Shake, 2002, Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects, Ann Thorac Surg, 73, 1919, 10.1016/S0003-4975(02)03517-8 Spees, 2016, Mechanisms of mesenchymal stem/stromal cell function, Stem Cell Res Ther, 7, 125, 10.1186/s13287-016-0363-7 González, 2015, Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells, Stem cells translational medicine, 4, 1109, 10.5966/sctm.2015-0022 Yamahara, 2014, Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells, PLoS One, 9, e88319, 10.1371/journal.pone.0088319 Rajala, 2011, Cardiac differentiation of pluripotent stem cells, Stem Cell Int, 2011, 383709 Wang, 2016, Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells, Stem Cell Res, 16, 522, 10.1016/j.scr.2016.02.032 Flanigan, 2004, A review of cardiac anatomy and physiology, Home Healthc Nurse, 22, 45, 10.1097/00004045-200401000-00011 van Veen, 2001, Cardiac gap junction channels: modulation of expression and channel properties, Cardiovasc Res, 51, 217, 10.1016/S0008-6363(01)00324-8 Lin, 2003, Regulation of connexin 43 gap junctional conductance by ventricular action potentials, Circ Res, 93, e63, 10.1161/01.RES.0000093379.61888.35 Eckardt, 2004, Functional role of connexin 43 gap junction channels in adult mouse heart assessed by inducible gene deletion, J Mol Cell Cardiol, 36, 101, 10.1016/j.yjmcc.2003.10.006 Lo, 1998, Cx43 gap junctions in cardiac development, Trends Cardiovasc Med, 8, 264, 10.1016/S1050-1738(98)00018-8 Lo, 2000, Role of Gap Junctions in Cardiac Conduction and Development, Circ Res, 87, 346, 10.1161/01.RES.87.5.346 Siegel, 2012, Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential, Stem Cell Dev, 21, 2457, 10.1089/scd.2011.0626 Jain, 2019, Comparison of the Cardiomyogenic Potency of Human Amniotic Fluid and Bone Marrow Mesenchymal Stem Cells, Int J Stem Cells, 12, 449, 10.15283/ijsc18087 Nartprayut, 2013, Cardiomyocyte differentiation of perinatally-derived mesenchymal stem cells, Mol Med Rep, 7, 1465, 10.3892/mmr.2013.1356 Witkowska-Zimny, 2011, Perinatal sources of mesenchymal stem cells: Wharton's jelly, amnion and chorion, Cell Mol Biol Lett, 16, 493, 10.2478/s11658-011-0019-7